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Most adenoviral vectors use in gene therapy protocols derive from species C. However, expression of the primary receptor (human
Coxsackievirus and Adenovirus receptor, hCAR) for these AdV is variable on cancer cells. In vivo targeting of a therapeutic gene to specific
cells has then become a major issue in gene therapy. The Ad fiber protein largely determines viral tropism through interaction with specific
receptors. Hereto, we constructed a set of HAdV5 vectors carrying chimeric fibers with knob domains from nonhuman AdV, namely from the
FAdV-1 (Aviadenovirus), DAdV-1, and BAdV-4 (Atadenovirus). Correspondents viruses were produced using an established new HEK293
cell line, which express the HAdV2 fiber. Recombinant HAdV harboring chimeric fibers constituted of the N-terminal domain of HAdV2,
and knob domain of bovine adenovirus type 4 (BAdV-4) demonstrated the greatest reduction in fiber-mediated gene transfer into human cells
expressing the hCAR. Moreover, this vector infects with a better efficiency than vector with wild-type fiber, the Chinese Hamster Ovarian
(CHO) and SKOV3 cell lines, both from ovarian origin, hamster and human, respectively. These studies support the concept that changing
the fiber knob domain to ablate hCAR interaction should result in a de- or retargeted adenoviral vector. The adenoviral vector with the
chimeric HAdV2/BAdV-4 fiber lacking hCAR interaction and with an ovarian cell tropism could be a nice candidate to elaborate vectors for
ovarian tumor therapy.
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Introduction Ad particles in vivo, the lack of specificity of vectors forGene transfer into human cells potentially offers an
elegant solution to a wide variety of medical problems.
Some biological properties of adenoviruses (Ad) make
them a rational choice as gene vectors for human gene
therapy protocols because they efficiently introduce DNA
into host cells, can be produced easily to high titers, and
are able to transduce a wide range of cell types (both
dividing and quiescent). Moreover, they are not inactivated
by complement in vivo and are not oncogenic in humans.
The most serious limitations of Ad as gene vectors proved
to be their immunogenicity, the suboptimal distribution of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.12.023
* Corresponding author. Inserm UR524, Institut de Recherche sur le
Cancer de Lille, place de verdun, 59045 Lille cedex, France. Fax: +33-3-
20-16-92-29.
E-mail address: jcd@lille.inserm.fr (J.C. D’Halluin).diseased tissues, and a poor infectivity for several cell
targets.
The natural targeting principally results from interactions
between cell surface proteins and two capsid components:
penton base and fiber. The homotrimeric fiber protein forms
a prominent spike that protrudes from each vertex of the
capsid. The fiber is anchored to the penton base by its N-
terminal domain, although its C-terminal domain mediates
attachment to cell receptors (reviewed in Chroboczek et al.,
1995). A trimerized fiber protein is absolutely required for
its incorporation into the viral particle, for binding to the
penton base (Novelli and Boulanger, 1991) and for the
interaction with cell receptors. The fibers from most of
human adenovirus serotypes including HAdV2/5 bind to a
46-kDa protein called human Coxsackievirus and Adenovi-
rus receptor (hCAR), expressed on the surface of many cells
(Bergelson et al., 1997; Tomko et al., 1997). However, not
Table 1
Ad fiber sequences, GenBank accession numbers, and properties of the
proteins
Virus Human
subgroup
Accession
no.
Fiber
size
(aa)a
Repeat
nb
Knob
size
(aa)
Human HAdV2 C NP_040533 582 21 189
HAdV3 B ERADF3 319 5 194
HAdV4 E S39300 426 11 184
HAdV5 C ERADF5 581 21 189
HAdV7 B ERADF7 325 5 194
HAdV9 D S37220 362 7 188
HAdV12 A NP_040933 587 22 185
HAdV15 D S32664 371 7 188
HAdV16 B AAA67203 353 7 198
HAdV17 D NP_049382.1 366 5 188
HAdV31 A S39297 556 21 184
HAdV35 B JC4774 323 5 187
HAdV40-small F NP_040875 387 11 163
HAdV40-large F NP_040876 547 20 182
HAdV41-small F ERADN1 341 11 163
HAdV41-large F ERADN2 562 21 182
Animal BAdV-3 AAD09736 976 46 181
BAdV-4 NP_077404 535 20 190
BAdV-10 AAL86539 1143 56 181
CAdV-2 Q65914 542 21 185
DAdV-1 (EDS) NP_044715 644 25 201
FAdV-1-smallb NP_043892 410 20 noc
FAdV-1-largeb NP_043891 710 35 212
FrAdV-1 NP_062452 429 14 186
MAdV-1(A) NP_015554 613 17 226
OAdV-287d AAA73919 543 25 121
odocoileus AAK32726 473 14 190
PAdV-4e AAB40001 703 6 580
SAdV-25 AAL35536.1 425 11 185
TAdV-3 NP_047400 454 14 188
The accession numbers of fiber proteins are given. The repeats number of
the shaft and the size of the knob domain were determined on the sequence
alignment (not shown), except for DAdV-1, the two fiber of the FAdV-1,
OAdV-287 and PAdV-4.
a aa, amino acids.
b CELO.
c The small fiber of the FAdV-1 devoid knob domain.
d Vrati et al., 1995.
e Kleiboeker, 1995.
L. Renaut et al. / Virology 321 (2004) 189–204190all adenoviruses recognize hCAR: HAdV-37 (species D)
uses sialic acid residues of host cell glycanes as its receptor
(Arnberg et al., 2000); human species B viruses (Defer et
al., 1990; Stevenson et al., 1995) and the shorter fiber of
human species F adenoviruses (Roelvink et al., 1998) have
an unknown receptor distinct from hCAR. The receptor for
specie B serotype 11 has been recently identified as the
CD46 (Segerman et al., 2003). Uptake of viral particles is
subsequently mediated through a specific interaction be-
tween an RGD sequence on the penton base and cell surface
integrins avh3–5 (Mathias et al., 1994; Wickham et al.,
1993).
The inability of HAdV to efficiently transduce some cell
populations, together with their lack of specificity, has
stimulated efforts to redirect adenoviral tropism from its
natural receptors to specifically selected surface receptors of
target cells. Until now, three approaches were used to target
specifically adenoviral vectors. The first was based on the
use of bispecific molecules recognizing simultaneously a
component of the viral particle (e.g., penton base or fiber)
and the targeted cell surface molecule (Douglas et al., 1996;
Goldman et al., 1997; Watkins et al., 1997; Wickham et al.,
1996a, 1996b, 1997a, 1997b). Bispecific antibodies directed
to the viral penton base and to either cell av integrins
(Wickham et al., 1996a, 1996b) or the CD3 molecules
(Wickham et al., 1997a, 1997b) were shown to increase
the efficiency of infection of the relatively adenovirus-
resistant endothelial, smooth muscle, or T lymphocytes
cells.
The second strategy to detargeting HAdV vectors is to
identify the residues involved in interaction between the
fiber and hCAR to modified them. The crystal structure of
the fiber knob domain of HAdV5 (Henry et al., 1994),
HAdV2 (vanRaaij et al., 1999), both from species C, and
HAdV12, species A (Bewley et al., 1999), has been deter-
mined by X-ray crystallography. It is a trimer with a three-
bladed ‘‘propeller’’ structure with a central surface depres-
sion. The structure of the HAdV5 fiber knob monomer is an
eight-stranded antiparallel sandwich composed of two h-
sheets, with loops and turns connecting the h-strands
(Henry et al., 1994; Xia et al., 1994). Structural analysis
and genetic approach show that the amino acids that are
involved in hCAR binding are localized to the side of the
fiber knob, involving residues in the AB loop, the B-sheet,
the DG loop (Roelvink et al., 1999), and the E- and F-sheets
(Kirby et al., 1999, 2000).
The third strategy is based on the use of viruses whose
fiber proteins have been genetically engineered to acquire a
novel binding specificity. The major obstacle to generating
newly targeted Ad vectors that have simultaneously lost
their original tropism and earn a new one is the trimeric
nature of the fiber protein. By changing the knob of HAdV5
with that of other serotypes, it is possible to modify the
affinity of Ad particles for some cells. HAdV5 vectors
harboring the knob of HAdV3 are able to transduce cells
normally resistant to HAdV5 (Krasnykh et al., 1996; Ste-venson et al., 1995, 1997). Similar approaches were used
with different knob domains of HAdV37 (Chiu et al., 2001),
HAdV9, HAdV17 (D) (Chillon et al., 1999; Zabner et al.,
1999), HAdV35 (Havenga et al., 2002; Rea et al., 2001;
Shayakhmetov et al., 2000). Ligands (polylysine and RGD
peptides) were also successfully inserted into the fiber
protein, generating viruses with extended tropism (Gonzalez
et al., 1999; Wickham et al., 1996a, 1996b, 1997a, 1997b).
However, the interaction of these viral particles with their
natural receptors was still retained, and these ligands bind
many cell types. Another approach to retarget HAdV
vectors is to use adenovirus serotypes different from
HAdV2/5. To this purpose, different Ad were used: HAdV7
(Abrahamsen et al., 1997), nonhuman Ad: canine Ad
(Kremer et al., 2000), and chimpanzee Ad (Farina et al.,
2001) and the Aviadenovirus FAdV-1 (Francois et al.,
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receptor or other receptor(s) expressed on many human cells
(Cohen et al., 2002; Soudais et al., 2000; Tan et al., 2001).
So we decided to explore an alternative strategy, which
consisted in constructing chimeric fibers with the C-terminal
domain from the fiber of Ad phylogenetically distant from
human HAdV2/5. In fact, more than 100 adenovirus sero-
types have been isolated from different animals and char-
acterized. They can be classified into, at least, four genera
named Mastadenovirus, Aviadenovirus, Atadenovirus
(Benko and Harrach, 1998), and Siadenovirus (Davison
and Harrach, 2002). We report, here, the possibility of using
a knob domain of the fiber protein from bovine adenovirus
type 4 (BAdV-4) and a bird Ad the DAdV-1 (the Egg Drop
Syndrome), both belonging to the new genus Atadenovirus,
to construct Ad vectors with a reduce tropism for many
human cells.Results
Sequence relationship among adenoviral fiber proteins
The last detailed analysis of fiber sequences compared 20
fiber proteins, representing the six human species A to F, as
well as other Mastadenovirus (Chroboczek et al., 1995). We
chose to include fiber sequences from the other three generaFig. 1. Phylogenic tree generated by parsimony analysis of fiber amino acid sequ
alignment of the fiber N-terminal domain involved in penton base interaction.including the two fibers of FAdV-1 (CELO) from the genus
Aviadenovirus, the fiber of bovine BAdV-4, a duck DAdV-1
(EDS virus), an ovine (OadV-287) and a deer (odocoileus)
Ad isolate from the genus Atadenovirus (Both, 2002) as
well as the frog Ad (FrAdV-1) and a turkey (TAdV-3),
which are now classified into the genus Siadenovirus
(Davison and Harrach, 2002). Of these 30 proteins, there
are two representatives from two human Ad species A and
C, three from D, four from species B, one from E, two from
F, the members of which contain two fibers genes. Addi-
tionally, six nonhumans Mastadenovirus, one Aviadenovirus
possessing two fibers, four Atadenovirus, and two Siadeno-
viruses are also presented. A variety of properties of the
fiber proteins are reported in Table 1. These proteins range
in size from 319 to 1143 residues, with the human subgroup
B proteins being the smallest and bovine adenovirus 3 and
10 proteins the largest.
The 30 fiber protein sequences were aligned using
CLUSTAL W. As expected, the highest levels of identity
and similarity occurred between viruses within the same
human Ad species (not shown). The high degree of relat-
edness between the fiber of HAdV-4 and SAdV-25 is in
agreement with earlier observations concerning the similar-
ity of the E1A large protein of the two viruses (Avvakumov
et al., 2002), and further supports their common species
classification and in a broader sense the establishment of Ad
species comprising both human and ape viruses (Benko¨ etences from adenovirus serotypes (A) and knob domain (B). (C) Sequence
L. Renaut et al. / Virology 321 (2004) 189–204192al., 2000). In a phylogenic tree based on full fiber sequences
(Fig. 1), the separation of five clusters could be seen. The
first branch contains the six human species and SAdV-25.Fig. 2. Sequence alignment of the adenovirus fiber knob domains. The sequences o
show conservation. Darker shading corresponds to higher levels of conservation. G
indicated with asterisks.The four other branches contain, respectively, the Aviade-
novirus, the nonhuman Mastadenovirus, the Atadenovirus,
and the Siadenovirus. From the aligned sequences and usingf the indicated adenovirus fiber proteins were aligned and gray shaded areas
aps are indicated as dots. The positions of the h-strands on HAdV5 fiber are
Fig. 2 (continued ).
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determine for each protein, the tail, the shaft with the repeat
number and the knob domain (Table 1).
We first examine the sequence homology at the N-
terminus part of the fiber proteins; this domain is responsi-
ble for the interaction with the penton base; interaction
requires for virus assembly. As shown in Fig. 1C, the
sequence FNPVYPY is well conserved in all human sero-
types and also in other Mastadenovirus. The core (PVYP)
appears in four Atadenovirus fiber N-terminus. In these fiber
proteins, the conserved motif is located between 9 and 15
from the first methionine residue except for human species
A Ad (18–24). The core motif is conserved in sequence and
in position for Aviadenovirus and Siadenovirus. Surprising-
ly, the penton base binding motif in the large fiber of the
FAdV-1 is located about 65 amino acids from the N-
terminus; this position can be explained by the presence
of two fibers at each capsid vertices.
Because the knob is responsible for the trimerization
initiation and for receptor recognition, we decided to realign
these domains (Fig. 2). The phylogenic tree based on the
fiber knob alignment (Fig. 1B) shows clustering of the
viruses examined into four distinct clusters, but these
clusters are not fully corresponding to those obtained basedon the full sequence alignments. The branches containing
the six human Ad species and SAdV-25 are conserved. The
knobs of the human species B Ad are the most different. The
phylogenetic relationship among the knob sequences of Ad
of different animal origin does not seem to follow that of the
host animals. For example, the knob of the longer fiber
protein of the FAdV-1 virus shares highest degree of identity
with the DAdV-1 virus knob. From Mastadenoviruses, fiber
knob domain of PAdV-4 has the greatest degree of diver-
gence, since the knob domain size (580AA vz 180–200AA)
(Kleiboeker, 1995) through the presence of the TLWT motif
at the beginning of knob. This motif appears as a signature
of all Mastadenovirus serotypes and is absent from other
species.
The low sequence identity between the knob domain of
human and nonhuman Ad, and the fact that we only have
structural information for three fiber knob domains
(HAdV5, HAdV3, HAdV12) prompted us to analyze the
predictable secondary structure of the knobs. Interestingly,
all knob domains from HAdV together with certain other
Mastadenovirus (BAdV-3, CAdV-2) have common second-
ary structure, in particular for the presence of the 10 h
strands (A to J) well identified in the 3D model. The knob
domain of the HAdV40 short fiber is characterized by a
L. Renaut et al. / Virology 321 (2004) 189–204194shorter sequence in the named DG loop in HAdV5. The
other knob domains present different secondary structures.
The DAdV-1 fiber and the large fiber from FAdV-1 are
similar, in particular for the presence of a putative a-helix at
the N-terminal domain of the knob. Two other Atadenovirus
(BAdV-4 and OdAdV) fiber knob domains have a similar
structure, characterized by the presence of many short h-
strands, but are different to that of DAdV-1.
The differences revealed in sequences and in structural
features of the knob domain encouraged us to examine the
possibility of using the C-terminal domain from non-Mas-
tadenovirus (FAdV-1, DAdV-1, BAdV-4) to obtain chimeric
fibers without affinity for the hCAR receptor.
Generation of HEK-293 cells constitutively expressing the
adenovirus 2-fiber protein
The elaboration and production of Ad particles harbor-
ing modified fiber, without hCAR affinity, required the
preparation of a packaging cell line. It is important to
ensure that fiber production continues during vector pack-
aging, which occurs in the late phase of productive viral
infection. For this purpose, we tested promoters fused to the
luciferase gene in adenovirus infected HEK-293 cells.Fig. 3. Construction of chimeric fiber genes. The positions of the fiber sequen
modifications resulted in the creation of a HindIII restriction site without modificati
large fiber the sequence, between repeat 21 and 22, GNNGL become GKL, and fo
The arrow indicates the separation between motif n and n + 1 in the shaft.Under these conditions, the strong promoter activity was
obtained with the CMV promoter (not shown) and selected
for the subsequent experiments. Efficient translation of late
viral mRNA is maintained by inclusion of the tripartite
leader (TPL), composed of three small exons that are
spliced onto the 5V end of late viral mRNA (Chow et al.,
1977). Addition of this sequence has been previously
reported to increase levels of protein expression even in
uninfected cells (Sheay et al., 1993). To ensure continued
translation of the recombinant fiber mRNA, different frag-
ments containing a combination of the HAdV5 TPL were
inserted at the 5V end of the luciferase gene in pC3-luc to
create a family of pC3-TPL-luc vectors. Infected and mock-
infected HEK-293 cells were transfected with both con-
structs and luciferase activity measured. From the results,
apparently, the better construct contains the second and
third exons of the TPL inserted downstream to the CMV
promoter (not shown). The HAdV2 fiber gene was inserted
in place of the luc gene into pC3-TPL-luc and an in vitro
translation assay was performed. The presence of TPL
increased the translation. The sequence neighboring the
initiation codon was also modified to create a Kozak’s
(1997) consensus; the modification introduces an alanine
codon at the 5V end of the fiber ORF between the codonsce modifications are indicated as their positions in the shaft repeats. All
on of the coding sequence except for the two FAdV-1 fibers. For the FAdV-1
r the small fiber the sequence, between repeat 9 and 10, GNF become GKL.
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the translation efficiency in an in vitro system. In in vitro
translation assays, the modification of the neighboring
initiation codon sequence upregulated fiber protein synthe-
sis. Moreover, the artificial construct containing a NotI
restriction site between TPL and fiber sequence drives
protein synthesis at the same level as the cDNA construct
(not shown), and was chosen for further experiments. This
construct was transfected into HEK-293 cells to obtain cell
lines expressing the fiber protein at a high level, and after
selection with geneticin, individual clones were expanded.
Fifty-one cell clones were evaluated by Northern blotting
and five clones were selected for further characterization.
These established cell lines were analyzed for the expres-
sion level of the fiber protein using immunoblotting and
immunofluorescence techniques. Finally, one clone (desig-
nated 247E) was retained to obtain and produce recombi-
nant adenovirus with chimeric fibers.
Construction of the chimeric fiber genes and analysis of
protein trimerization
As noted above, the native fiber protein is a homotrimer
and trimerization is essential for assembly of the penton.
Because the N-terminal domain of the fiber from non-
Mastadenovirus is not conserved, in particular for the
sequence involved in interaction with the penton base, weFig. 4. Analyses of trimerization of the chimeric fiber proteins. (A) The chimeric fi
and analyzed in 12.5% gels by PAGE under nondenaturing conditions. (B) In v
HAdV2/BAdV-4. Proteins from transfected cells were prepared 40 h after transf
proteins were revealed by immunoblotting using a monoclonal antibody. The arrow
fiber proteins. (C) Ad vectors with chimeric fibers were produced in HEK-293 ce
transferred onto a membrane, fiber proteins were revealed with a monoclonal anti
type HAdV2 virus; lane 2, no virus; lane 3, HAdV2-hGal; lane 4, HAdV2/DAdVdecided to retain the HAdV2 fiber N-terminus domain and
to join it to the C-terminus fibers in the shaft domain,
without modification of the two small h-strands of this
domain. The chimeric fiber genes were constructed after the
creation of a HindIII site (Fig. 3) and exchange of the 3V
sequence of the fiber genes. To assess the multimeric
structure of the chimeric fiber protein, an in vitro test was
performed and chimeric fiber proteins were analyzed under
nondenaturing conditions. As shown in Fig. 4A, the syn-
thesized proteins migrated at the predicted molecular mass
for trimer (ranging between 120 and 200 kDa), except for
the chimeric HAdV2/BAdV-4 fiber protein that appeared
only as a monomer (62 kDa). Surprisingly, the control
BAdV-4 fiber protein was seen only as a monomer, in this
in vitro test (not shown), though in the viral capsid the
BAdV-4 fiber protein is probably a trimer. To evaluate the
homotrimerization of the chimeric HAdV2/BAdV-4 fiber
protein in mammalian cells, transient expression was per-
formed in COS cells after transfection of pC3Fb/HAdV2/
BAdV-4. The fiber proteins were visualized by immuno-
blotting after electrophoresis under nondenaturing condi-
tions. As shown in Fig. 4B, the fiber proteins appeared as a
trimer when synthesized in vivo, but the trimerization
efficiency appears reduced compared to the HAdV2 fiber.
This result allowed us to construct and produce recom-
binant Ad with chimeric fiber proteins, including the
HAdV2/BAdV-4.ber proteins were synthesized in vitro as described in Materials and methods
ivo analysis. COS cells were transfected with pC3Fb/HAdV2 and pC3Fb/
ection and separated by SDS-PAGE after (D) or before (N) heating. Fiber
s indicate the monomeric (empty arrow) and trimeric (full arrow) forms of
lls and purified. Viral proteins were separated by SDS-PAGE and proteins
body directed against the N-terminal part of the fiber. Lane 1, control wild-
-1-1; lane 5, HAdV2/DAdV-1-2; lane 6, HAdV2/BAdV-4.
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proteins
All plasmids containing the modified full-length HAdV5
genomes (Fig. 5) were constructed by homologous recom-
bination in Escherichia coli and contain the bacterial h-
galactosidase gene under the control of the CMV early
promoter. Using shuttle plasmids harboring the chimeric
fiber genes (p5Shut/HAdV2/XXX) and the pRECad, a set of
plasmids containing the recombinant HAdV-5 genomes
were constructed.
The strategy used to obtain recombinant vectors without
affinity for the receptor hCAR (or being a low affinity for
this receptor) is based on the amplification of vectors
harboring two fibers: wild type and chimeric. Transfection
of the linearized pRECad/BAdV-4, pRECad/FAdV-1-L,
pRECad/FAdV-1-S, pRECad/DAdV-1-1, and pRECad/
DAdV-1-2 plasmids into the 247E cell line and amplifica-
tion cycles (3 to 5) allowed the production of large stocks
of HAdV2/XXX containing the recombinant chimeric fiber
gene in the HAdV5 genome, except for HAdV2/FAdV-1-S.
This last construct was propagated during 10 passages
without real amplification with the impossibility to purify
viral particles. The resulting virus stocks from other con-
L. Renaut et al. / Viro196Fig. 5. Generation of the adenovirus genomes with a chimeric fiber gene. The p5S
pBS-SK. The MluI and SalI restriction sites were created by site-directed mutagen
constructed by replacing the 3V end of the HAdV2 fiber gene in the pFIB/HAdV2
chimeric fiber genes between nt 31041 and 32788 were constructed. pRECad was
generated fragments were co-introduced into electrocompetent E. coli Top10FV cell
given relative to the HAdV5 sequences. The SalI site inserted into the fiber genestructs were used to infected HEK-293 cells and produced
recombinant Ad vectors containing the chimeric fiber gene.
These viral particles contain only the modified fiber
proteins.
The state of maturation and protein content of all
recombinant Ad particles were compared by SDS-PAGE
analysis of virus preparations. The infectious viruses were
purified by isopycnic CsCl gradient. SDS-PAGE analysis of
the viruses showed that the maturation of the viral particles
is not altered by the presence of chimeric fibers (not shown).
The different precursor proteins were cleaved into mature
proteins, in particular, the protein pVII. Viral proteins were
transferred onto membrane and fiber proteins were revealed
with a monoclonal antibody. As shown in Fig. 4C, all virus
particles harbor the attended proteins.
Cell tropism
A panel of human cell lines was tested for their sensi-
tivity toward chimeric fiber vectors by determining the level
of the h-galactosidase activity (Fig. 6). The vector harboring
the HAdV2/FAdV-1-L fiber showed the same infectivity
profile as the vector with wild-type fiber (Fig. 6A). The two
constructs with DAdV-1 show a different outcome, thehut was obtained by insertion of PCR amplified fragment from pBHG11 in
esis at the indicated position. The set of plasmids pFIB/HAdV2/XXX was
by heterologous fiber gene. Then, the p5Shut/HAdV2/XXX containing the
linearized with PacI and p5Shut/HAdV2/XXX with NotI and KpnI, and the
s. The deletion in the E3 region, fiber gene, and restriction site positions are
, upstream to the polyA signal, is indicated in italic.
Fig. 6. Study of the cell tropism of the modified Ad vectors. (A and B) A549 cells were infected with an increasing amount of HAdV2, HAdV2/FAdV-1-L (A)
and HAdV2, HAdV2/BAdV-4, HAdV2/DAdV-1-1, and HAdV2/DAdV-1-2 (B). Twenty-four hours after infection, the h-galactosidase activity was determined
by FACS analysis. The results are expressed as the percent of positive cells. (C) HeLa cells were infected with an increasing amount of viral particles, 0, 0.5, 1,
2, 4, and 8.103 PP (Physical Particles) per cell from front to back, respectively. (D) HepG2 cells were infected and analyzed under similar conditions as in (A).
Results are expressed as an average of the Relative Fluorescence Intensity (RFI). (E) Comparison of infectivity of the HAdV2/BAdV-4 produced in HEK-293
(Hyb/293) or in HEK-293 cell line expressing the HAdV2 fiber protein (Hyb/247E).
Fig. 7. hCAR-independent infection of CHO cells by hybrid Ad vector
harboring the HAdV2/BAdV-4 chimeric fiber. CHO cells expressing or
not the hCAR receptor were infected with 1.103 (white) or 3.103 (black)
PP per cell of parental or hybrid vector. Twenty-four hours after
infection, the h-galactosidase reporter activity was determined by FACS
analysis and shown as the percent of positive cells.
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human cells at lower level than HAdV2. The construct with
the large fiber (HAdV2/DAdV-1-1) was not capable of
infecting human cells (Fig. 6B), confirming a recent report
that demonstrates that the artificial extension of the fiber
shaft inhibits infectivity (Seki et al., 2002).
The vector with HAdV2/BAdV-4 fibers showed a re-
duced capacity to infect human cells (B, A549; C, HeLa; D,
HepG2). To obtain a similar level of reporter activity, the
MOI was increased to about 10 to 20 times that of the
HAdV2 (Figs. 6B–D). The weak infectivity observed with
the HAdV2/BAdV-4 fiber vector might be the result of a
very low affinity for hCAR, or nonvisible defect in viral
particle maturation. We analyzed the level of cell infectivity
of the vector produced in the HEK-293 cell line expressing
the wild-type fiber (247E). With this produced vector, an
intermediate profile between the HAdV2 and HAdV2/
BAdV-4-fiber vector produced in HEK-293 was obtained
(Fig. 6E) suggesting that the level of h-galactosidase
obtained with HAdV2/BAdV-4 fiber vector is not due to
the presence of too much wild-type fiber. To further confirm
these results, the viral particles produced in HEK-293 cells
expressing the fiber protein were also analyzed by Westernblotting to determine the ratio between chimeric and wild-
type fiber proteins in the capsid. With this technique, the
HAdV2 fiber was not detectable though the viral particles
produce in 247E cells. Taken together, these results suggest
Fig. 8. Study of the cell tropism of the modified Ad vectors in ovarian tumor cell lines. (A) The SKOV3 cells were infected with increasing amounts of viral
particles, 0, 0.5, 1, 2, 4, and 8.103 PP per cell. Twenty-four hours after infection, the h-galactosidase activity was determined by FACS analysis. The percentage
of positive cells was expressed as a function of the virus input. (B) Different ovarian tumor cell lines were infected with 1.103 PP/cell of HAdV2/BAdV-4, and
24 h after infection, the h-galactosidase reporter activity was determined by FACS analysis and shown as the percent of positive cells.
L. Renaut et al. / Virology 321 (2004) 189–204198the presence of the wild-type fiber at a low level, probably
one wild-type fiber capsomer for more than one particle.
To analyze the interaction between vectors with chimeric
fiber and the hCAR receptor, the infectivity of Chinese
Hamster Ovarian (CHO) cells expressing or not hCAR were
compared. In opposition to wild-type-fiber vectors, no
difference in infectivity was observed with the HAdV2/
BAV-4-fiber vector in the two CHO cell lines (Fig. 7). These
results suggested that the weak infectivity observed with the
HAdV2/BAdV-4 vector is not the result of very low affinity
for hCAR. Surprisingly, this chimeric fiber vector infects
very efficiently the parental CHO cells, suggesting the
presence of one nonidentified specific receptor on these
cells. This result also confirms normal maturation of the
modified vector, because these hybrid vector particles infect
efficiently CHO cell line.
The infectivity of Chinese Hamster Ovarian (CHO) cells,
an ovarian cell line, prompt us to analyze the tropism of the
vector with chimeric fiber to human ovarian cancer cells.
The well-characterized SKVO3 cell line was infected withFig. 9. Competition experiments. The SKOV3 cells were infected with
increasing amount of HAdV5 viral particles, 0, 1.104, or 1.105 PP/cell
incubated 2 h at 4 jC, and then 1.103 PP/cell of FAM-labeled HAdV2
(black boxes) or HAdV2/BAdV-4 (open boxes) were added and incubation
maintained at 4 jC for 60 min. After washing and fixation, the binding
efficiency was determined by FACS. The results are expressed as the
percentage of binding relative to the binding without competitor and are the
average of two independent experiments realized in triplicate.increase amount of both vectors, and reporter gene expres-
sion was determined 24 h after infection. As shown in Fig.
8A, the SKOV3 cell line appears more permissive to the
vector with the chimeric fiber than the control vector.
Similar results were obtained in the OWCAR3 and
IGROV1, two other ovarian cancer cell lines (Fig. 8B).
In order to confirm that the vector with chimeric fiber
recognizes a receptor different from the hCAR, competition
experiments were performed using SKOV3 cell line, be-
cause this cell line was permissive to both vectors. As
shown in Fig. 9, HAdV5 was able to complete the binding
of the vector with the HAdV2 fiber but not the vector
harboring chimeric fiber.
These results suggest that adenoviral vector with the
chimeric fiber HAdV2/BAdV-4 recognizes a receptor
expressed on the ovarian cells, which is different from the
hCAR. Further analyses using cells obtained from patients
will help us to confirm our results. Then we will identify the
specific ovarian receptor to develop vector for ovarian
cancer gene therapy.Discussion
The generation of a truly redirected adenoviral vector for
a specific cellular type would require the combination of
two events: the hCAR detargeting and the addition of a new
tropism. These two goals can be obtained by different
simultaneous approaches or by separate events. The detar-
geting could be fulfilled in two ways: mutation of the knob
or the replacement of the entire knob domain of the
adenovirus fiber protein.
Here, we investigate another possibility, which consists
in the use of the C-terminal domain of fiber proteins from
Ad phylogenetically distant from human HAdV2. This
proposal was supported by preliminary experiments, which
showed, for example, that the BAdV-4 viral particles were
unable to infect human cells (MB and JCD, unpublished
results). Moreover, published results concerning the use of
different Ad serotypes as gene vectors suggest the possibil-
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Francois et al., 2001; Kremer et al., 2000).
We constructed Ad vectors containing chimeric fibers
using the knob of FAdV-1, DAdV-1, and BAdV-4. To
produce recombinant Ad harboring a chimeric fiber, differ-
ent approaches are available. First, the modified fiber gene
is inserted into the adenovirus genome in the place of the
fiber gene, and the virus is produced in the HEK-293 cell
line. This system required the recognition of the hCAR
receptor or another receptor expressed on the cell surface. In
the absence of this recognition, it is necessary to obtain a
new cell line derived from HEK-293 cells or other permis-
sive cells that express a receptor recognized by the new
fiber. A second strategy is to produce recombinant Ad
deleted of the fiber gene in HEK-293 cells expressing the
recombinant fiber at a high level. This system requires the
expression of the fiber protein at a level similar to that
obtained during the lytic cycle. In fact, a lower production
reduces the amplification of Ad particles at principally the
maturation step (Legrand et al., 1999). Taken advantages of
these two strategies, we developed a third system, which is a
combination of the two previously mentioned systems
where the chimeric fiber gene is introduced into the Ad
genome. The initial amplifications of the recombinant Ad
were performed in HEK-293 cells expressing the wild-type
fiber. During these amplification steps, the viral particles
contain two distinct fibers: the chimeric fiber and the wild-
type fiber, which allows for hCAR-dependent infection of
HEK-293 cells. The final step is a lytic cycle in HEK-293
cells to obtain viral particles harboring only the modified
fiber.
The level of the HAdV2 fiber synthesized in the 247E
cell line, in conjunction to high level of chimeric fiber,
allows for the production of viral particles harboring two
different fiber proteins. However, the level of the wild-type
fiber observed using immunoblotting appears to be very low
in produced viral particles in the transcomplementing cell
line. This ratio can explain the intermediate profile observed
in cell infection with the hybrid vector (Fig. 6E).
All analyzed fiber proteins, except that of BAdV-4, and
their corresponding chimeric constructs are able to trimerize
both in vivo and in vitro (Fig. 4). The BAdV-4 fiber and the
HAdV2/BAdV-4 chimeric fiber proteins were unable to
form a trimer in vitro, but these proteins can trimerize in
vivo, suggesting the possible involvement of a cellular or
viral encoded protein(s) as a folding protein. Another
explanation could be that the protein concentration is too
low to allow in vitro trimerization. Moreover, apparently,
the BAdV-4 fiber knob is less stable than other fiber knobs,
as suggested by the in vivo synthesis (Fig. 4B) and the
structural analyzes, in particular by the presence of many
putative short h-sheets and one a-helix, which is absent in
other fiber knobs. These hypotheses are not mutually
exclusive.
The presence of the chimeric fiber genes in the genome
of the obtained Ad vectors can allow for efficient maturationof the viral particles, because fiber protein(s) was(ere)
synthesized in large amount. In fact, optimal maturation of
AdV particles requires a high level of fiber proteins,
correctly folded, as previously reported for HAdV2 ts
mutants defective in fiber protein (D’Halluin et al., 1980)
and more recently for deletion constructs (Legrand et al.,
1999).
The virus harboring the hybrid HAdV2/DAdV-1 fibers
has different properties in human epithelial cell infection;
the shorter fiber has a profile intermediate to that of HAdV2/
BAdV-4 and of HAdV2 (Fig. 6B). The viral particles with
the longer fiber were unable to infect the A549 cell line,
despite of the presence of the same knob domain, confirm-
ing in this manner the importance of the longer shaft in cell
infection, as described for an artificial extension of the fiber
shaft domain (Seki et al., 2002).
The recombinant vector with hybrid HAdV2/FAdV-1-L
fiber infects all tested human cell lines with the same profile
as that of the HAdV2 fiber (Fig. 6A). This result is
compatible with previous reports showing that FAdV-1 virus
with a deletion in the large fiber gene was unable to infect
mammalian cells by lost of the interaction with hCAR (Tan
et al., 2001). In contrast, we were unable to obtain and
purify the recombinant vector with the chimeric fiber
construct with the small FAdV-1 fiber. We observed a weak
cytopathic effect after 10 passages without real amplifica-
tion in HEK-293 cells expressing the HAdV2 fiber. This
result suggests that viral production results only by incor-
poration of the ‘‘cellular’’ expressed fiber and that the
chimeric fiber is unable to insert correctly into the penton
base. The chimeric fiber trimerizes with a high efficiency, in
vitro (Fig. 4) and in vivo (not shown), through the absence
of the knob domain; the trimerization domain appears also
localized in the C-terminal part of the molecule (not shown).
Further analyses are required to determine precisely the
defect in production of this vector.
The viral particles expressing the hybrid HAdV2/BAdV-
4 fiber protein show a low affinity for most part of all tested
human cell lines. The infectivity was reduced to a ratio of 1
to 5–10 compared to the HAdV2 fiber. This weak reduction
can be explained by the presence of the RGD sequence on
penton base. In fact, it clearly demonstrated that the aboli-
tion of both receptor binding domains is required to abolish
the natural targeting (Einfeld et al., 2001). In opposition,
this construct infects CHO cells expressing or not the hCAR
with the same efficiency and at a level higher than that of
the parental vector. Moreover, this construct shows a re-
duced affinity for hepatic cells, at least in vitro (Fig. 6D). In
fact, the vector dissemination and its catching by the liver
are probably major problems to use Ad in gene therapy
protocols. This result suggests that the BAdV-4 fiber knob
recognize another receptor than hCAR, which is present on
CHO, SKOV3, OWCAR3, and IGROV1 cells, four ovarian
cell lines. This result was confirmed by competition experi-
ments (Fig. 9). The adenoviral vectors are used in different
gene therapy assays for ovarian tumors (Alvarez et al.,
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gene expression appears often at a low level, which results
to the variable expression of the hCAR on tumor cells (Kim
et al., 2002). This defect can be overcome by modifications
of the viral vector as the insertion of peptide in the HI loop
of the fiber protein (RGD or FGF2) (Biermann et al., 2001;
Blackwell et al., 2000; Dmitriev et al., 1998; Kanerva et al.,
2002; Rancourt et al., 1998; Vanderkwaak et al., 1999).
These insertions allow an efficient gene transfer into ovarian
tumor cells, but increase the viral tropism for most part of
normal cells. So HAdV2/BAdV-4 can be a nice prototype as
gene vector for ovarian cancer cells because it has no (or at
least a reduced) affinity for hCAR. We will now determine
the receptor recognized by the knob domain of BAdV-4
fiber. Our system developed with a chimeric fiber is the first
step toward the construction of new Ad vectors lacking
interaction with hCAR.Materials and methods
Cell lines
The HEK-293, HeLa, A549, HepG2, COS, SKOV3, and
CHO cell lines were purchased from ATCC and cultured in
Dulbecco medium supplemented with 10% new-born calf
serum. OVCAR3 and IGROV1 cell lines, a generous gift of
Be´tina Couderc, were cultured in the same conditions. CHO
cells expressing the hCAR receptor were obtained from
Bergelson and grown in aMEM medium (Bergelson et al.,
1997).
Cell lines expressing the HAdV2 fiber protein
The vector expressing the HAdV2 fiber protein (pC3Fb)
was previously described (Renaut et al., 2002). The TPL
exons were amplified by PCR using a couple of specific
oligonucleotides: 1-F/5V, 5V-AggAAAAAAgAAgCTTCTCT-
CTTCCgCATCgCTgTCTgCg-3V; 2-F/5V, 5V-AggAAAAAA-
gAAgCTTCTCgCggTTgAggACAAACTCTTCgC-3V; 3-F/
5V, 5V-AggAAAAAAgAAgCTTgTACTCCgCCACCgAgg-
gACCTgAgC-3 V; 2 -R / 3 V, 5 V-AggAAAAAAggC-
ggCCgCCgTTCggAggCCgACgggTTTCCg-3V; 3-R/3V, 5V-
AggAAAAAAggCggCCgCTTgCgACTgTgACTggTTA-
gACgCC-3, and in fiber gene (R), 5V-CCTgAgTTgT-
CAAAACTTAAACCCgCTC-3V, inserted between the
CMV promoter and the fiber gene in the pC3Fb after
digestion with appropriate restriction enzymes to give pC3-
TPLnnn-Fb (nnn represents the TPL exon). The same ampli-
fied TPL exons were inserted between the CMV promoter
and the luciferase gene into pC3luc, a derivative of pC3Fb
harboring the luciferase gene in the place of the fiber gene.
The sequence neighboring the initiation codon of the fiber
gene was also modified to obtain a Kozak’s consensus
(Kozak, 1997) by PCR amplification using the oligonucleo-
tide: W5V-AggAAAAAAgCggCCgCCACCATggCgAAA-CgCgCCAgACCgTC-3V, which results in the insertion of
an alanine residue between the residues methionine and
lysine.
HEK-293 cells (4.106) were transfected with 5Ag of pC3-
TPL23-Fb; after 3 weeks of selection with G418 (400 Ag/
ml) (Roche), individual clones were expended. Fiber gene
expression was analyzed by Northern blotting using stan-
dard procedure as previously described (Hamdane et al.,
1997) and then by immunoblotting.
Fiber amplification and generation of chimeric fibers
All adenoviruses used in this study were propagated in
specific cell lines, and viral DNA from infected cells or from
viral particles was isolated as described previously (D’Hal-
luin et al., 1978; Gomes et al., 1992). Fiber genes were PCR
amplified with distinct sets of specific oligonucleotides:
BAdV-4: 5V-AggAAAAAAgCggCCgCATgAAAAgAgC-
ACgTTg-3V and 5V-AggAAAAAAggTCgACTTATATCg-
ATTgCgTgCgAgTTATgC-3V; FAdV-1-L: 5V-AggAAAAA-
AgCggCCgCCATggAggAggTTCCCCTAAAgCgTg-3V
and 5V-AggAAAAAAggTCgACTTATATCgATTgATAgT-
ACCCCAgATAAg-3V; FAdV-1-S: 5V-AggAAAAAA-
gCggCCgCCATggCggACCAgAAAAggAAgCTgg-3V and
5V-AggAAAAAAggTCgACTTATATCgATACCgTA-
ACgggggCgCgggC-3V; DAdV-1: 5V-AggAAAAAAggC-
ggCCgCCATggCgAAgCgACTACggTTggACCCT-
gATCC-3V and 5VAggAAAAAAggTCgACTACTgTgCT-
TACTgTgCTCCAACATATgTAAAg-3V. Fiber sequences
were subsequently cloned in a NotI- and SalI-digested pBS-
SK plasmid (Promega), thus generating plasmids coded
pFIB/XXX (XXX represents the adenovirus from which the
fiber was amplified).
To construct chimeric fiber genes, HindIII restriction
sites were introduced or removed in fiber genes by site-
specific mutagenesis using specific oligonucleotides as
previously described (Hamdane et al., 1997); HAdV-2:
5V-gAgCgggTTTAAgTTTTgACAACTCAgg-3V and 5V-
gTCAgATggAAAgCTTgCCCTgCAAACATC-3V, DAdV-1:
5 V- g T TAAAATT g g CC gAT g g C A A g C T T g g T g -
TAAATgTgggCCTTggg-3V, FAdV-1-L: 5V-gCggACCCCT-
CACCAgCggCAAgCTTAgCTTAgCggCCgTCACACC-3V,
FAdV-1-S: 5V-gTCCTCCCCTACgggCAAgCTTgTgAgCTC-
TAgCAACAACC-3V, and BAdV-4: 5V-CCCggAgg-
gAAAgCTTTTTATACAACTATC-3V. These mutations do
not modify the sequence of the fiber proteins. The chimeric
fiber genes were obtained by replacing the 3V end of the
HAdV2 fiber gene in pFIB/HAdV2 by the HindIII–SalI
fragment of each other fiber from pFIB/XXX plasmids to
give the pFIB/HAdV2/XXX (Fig. 5).
In vitro trimerization test
The chimeric fiber genes were cloned into the pC3-
TPL23 vector allowing for in vitro synthesis with the
TNT T7 Quick Coupled Transcription/Translation System
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(Amersham). Synthesis was performed at 30 jC for 90 min
with a chase period of 30 min. Synthesized proteins were
analyzed by PAGE.
For the in vivo trimerization test, COS cells (3.106) were
transfected with 5 Ag of the appropriate plasmid, and 40
h after transfection, cells were washed twice with PBS,
lysed with five pulses of ultrasound. Lysates were clarified
by centrifugation at 13000  g for 30 min, proteins were
resolved on 8% polyacrylamide gels and transferred onto
an Immobilon P membrane (Millipore). Blots were probed
with an anti-fiber monoclonal antibody: MS-1027-p0
(Microm, France) (10 Ag/ml). Immunoreactive proteins
were detected with the ECL reagent system (DuPont,
NEN).
Construction of the shuttle plasmid and generation of
viruses with a chimeric fiber
Plasmid p5Shut contains the HAdV5 viral genome se-
quence from the pBHG11 (Microbix) (nt 25690 until the nt
34322) with a deletion in the E3 region (nt 27865–30995).
After PCR amplification using the specific oligonucleotides:
5V-TTgTATAAAAAgCgCggCCgCAACTACCTTGCC-
TACCACTC-3V and 5V-TTgTATAAAAAgCgTCgAC-
CCTCCCgTgTgTgACTCgCAg-3V, this fragment was
inserted into the NotI- and XhoI-digested pBS-SK vector.
Two mutations were obtained in this construct, a MluI
restriction site was introduced into the HAdV5 fiber gene
at the same position as in the HAdV2 fiber gene (codon
68) and a SalI site was inserted just before the polyA
signal of the L5 region using the specific oligonucleo-
tides: 5V-CCCCCTggggTACTCTCTTTACgCgTATCC-
CgAACCTCTAgTTACC-3V and 5V-CTTACACTTTTTCA-
TACATTgTCgACgAATAAAgAATCgTTTgTgTTATg-3V,
respectively. The different chimeric fiber genes were intro-
duced into the MluI- and SalI-digested shuttle vector to
give the p5Shut/HAdV2/XXX constructs. Finally, the gen-
eration of adenoviral full-length genomes containing chi-
meric fiber genes was obtained by homologous
recombination in the E. coli Top10FV strain with 1 Ag of
PacI linearized pRECad and 500 ng of NotI/KpnI DNA
fragment from p5Shut/HAdV2/XXX as previously de-
scribed (Renaut et al., 2002). The pRECad is a plasmid
containing the HAdV5 genome with a deletion in E3 region
and the E1 region replaced lac Z gene under the control of
CMV promoter (Renaut et al., 2002). Verification of the
plasmids was performed using HindIII digestion.
Full-length recombinant adenoviral genomes were first
excised from pRECad/XXX with the SwaI restriction en-
zyme. The digestion products were transfected into HEK-
293 cells expressing the HAdV2 fiber (247E line) by lip-
ofection (Lipofectamine, Life technology). After 5 days,
cells were lysed by heat shock and pelleted. Supernatants
were used to infect 247E cell line. Five rounds of infection
were performed and viral particles were purified using astandard procedure (D’Halluin et al., 1978). The purified
viruses were used to infect HEK-293 cells, and the viral
progeny was also purified using the same procedure. The
virus titer expressed in viral physical particles (PP) per
milliliter was determined by UV absorption.
Sequence manipulation
Alignments of the fiber proteins were performed with
CLUSTAL W (Thompson et al., 1994) (http://www.ebi.ac.
uk/clustalw) using default parameters. The evolutionary tree
was displayed with the program proposed by Saitou and Nei
(1987) using the Vector NTI suite (Informax, Oxford, UK).
Secondary structure predictions for each fiber protein were
performed using the program PSIPRED (McGuffin et al.,
2000) (http://bioinf.cs.ucl.ac.uk/psiform.html).
Adenovirus labeling
The conjugation of adenoviral proteins to the carboxy-
fluorescein succimide ester was performed in 0.1 M car-
bonate sodium, pH 8.3, as recommended by the
manufacturer. 5(6)-Carboxyfluorescein (40 Ag/ml) and
HAdVs were incubated together for 30 min at room tem-
perature (RT). The reaction mixture was then transferred to a
dialysis chamber (10 000 MW cutoff, Slyde-A-Lyser,
Pierce). Two changes in dialysis buffer (10% glycerol, 10
mM Tris–HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2)
were performed overnight at 4 jC. SDS-PAGE analysis of
5(6)-carboxyfluorescein-HAdVs were performed: 50 Ag of
labeled and unlabeled protein was separated on a 4–12%
gradient SDS-PAGE and visualized by Coomassie blue
staining and fluorography (STORM 860). The dialyzed
mixture were brought to 30% glycerol and stored at 20
jC until using.
Competition experiments
SKOV3 cells were first incubated 120 min at 4 jC in
serum-free medium in the presence of increasing amount of
HAdV5 and then 103PP/cell of FAM-labeled HAdV5 or
HAdV2/BAdV-4 were added and incubated 60 min at 4 jC.
After rinsing once in PBS/BSA 1%, fixation in 1% para-
formaldehyde (PFA) for 10 min at RT was done. Cells were
then resuspended in 1 ml of PBS/BSA (1%) and fluorescent
flow cytometric analyses were performed with an EPICS
XL MLC Coulter flow cytometer. The percentage of posi-
tive cells was calculated based on the binding of FAM-
labeled virus without competitor.
Reporter activities
The h-galactosidase activities were determined using
FACS. For this purpose, cells were infected with the desired
MOI of virus as indicated in the figure legends. Twenty-four
hours after, cells were washed and FACS analyses were
L. Renaut et al. / Virology 321 (2004) 189–204202performed after reaction with FDG (fluorescein DI-(h-D-
galacto-pyranoside)) at 1 Ag/ml as recommended by the
manufacturer (Sigma).Acknowledgments
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